Biopharmaceutical News and Research

RSS

Enable Injections enters into a development agreement with Genentech

Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.

21 Aug 2019

MSD collaborates with Francis Crick to find causes of motor neurone disease

Scientists at global biopharmaceutical company MSD and the Francis Crick Institute have started a unique new collaboration to understand the causes of Motor Neurone Disease and identify potential targets for future treatments, co-funded by MSD and the UK Medical Research Council.

21 Aug 2019

Albumedix ground-breaking ceremony

May 8th marked a big day in Albumedix’s history. Holding a traditional ground-breaking ceremony; our workforce, builders and contractors all gathered to watch Peter Rosholm (Chief Executive Officer) and Stuart Woodward (Chief Manufacturing Officer) take the first official step towards the company’s expansion.

From Albumedix Ltd. 20 Aug 2019

Mallinckrodt publishes results of StrataGraft regenerative tissue Phase 1b study

Mallinckrodt plc, a leading global biopharmaceutical company, today announced publication of results of its Phase 1b clinical trial of StrataGraft, an investigational regenerative tissue, in Burns, the journal of the International Society for Burn Injuries.

16 Aug 2019

Sartorius Stedim Biotech announces launch of new services for mammalian cell bank manufacturing

Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions.

From Sartorius 13 Aug 2019

Promising antibody therapy reduces tumor growth, increases survival in mice with pancreatic cancer

Scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion.

31 Jul 2019

Alzheimer's Association awards $3 million grant to support Longeveron's innovative clinical trial

The Alzheimer's Association has awarded Longeveron LLC, a Miami-based biopharmaceutical company that develops cellular therapies for aging-related diseases, a $3 million grant to be applied to the company's mesenchymal stem cell Alzheimer's research.

23 Jul 2019

Four young scientists receives Damon Runyon-Sohn Pediatric Cancer Fellowship Award

The Damon Runyon Cancer Research Foundation has named four outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Fellowship Award, committing nearly $1 million to help address a critical shortage of funding for pediatric cancer research.

17 Jul 2019

Quanterix to convene leading industry researchers at Alzheimer’s Association International Conference 2019 following closing of UmanDiagnostics acquisition

Quanterix marks major milestones as it continues to expand its footprint in neurology and lead the digital biomarker revolution across healthcare.

From Quanterix 11 Jul 2019

New alliance will focus on the structural visualization of novel druggable sites

PhoreMost has entered into an alliance with CCBT in India for the structural visualization of novel druggable sites across multiple targets.

From PhoreMost 8 Jul 2019

Sartorius launches new ambr 250 modular bioreactor vessel for cell and gene therapy applications

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, today launched a new vessel for its ambr 250 modular benchtop automated mini bioreactor system.

From Sartorius 28 Jun 2019

Quanterix announces agreement to acquire UmanDiagnostics, world’s leading neurofilament light (Nf-l) antibody supplier

Quanterix announce agreement to acquire privately held UmanDiagnostics AB for $22.5 million.

From Quanterix 26 Jun 2019

PhoreMost and C4XD sign neurodegeneration drug discovery collaboration agreement

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and C4X Discovery Holdings plc, a pioneering drug discovery company, today announced they have signed a neurodegeneration drug discovery collaboration agreement.

From PhoreMost 25 Jun 2019

Investigational drug for treatment of sickle cell disease shows early promise in clinical trials

An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European Hematology Association Congress in Amsterdam this week.

20 Jun 2019

Researchers identify new clues on tissue damage in rheumatoid arthritis and lupus

Research supported by the Accelerating Medicines Partnership on Rheumatoid Arthritis and Systemic Lupus Erythematosus provides new insights into tissue damage for these autoimmune conditions.

19 Jun 2019

Topical cream found to be effective in reversing the effects of vitiligo

A nationwide phase II clinical trial, coordinated out of Tufts Medical Center in Boston, has found that a topical cream was extremely effective in reversing the effects of vitiligo, a relatively common autoimmune disease that causes loss of skin pigmentation.

17 Jun 2019

NCCN and AstraZeneca collaborate to improve care processes for lung cancer patients

The National Comprehensive Cancer Network Oncology Research Program and AstraZeneca, a global, science-led biopharmaceutical company, are collaborating to seek proposals for improving care processes for patients with unresectable stage III and stage IV non-small cell lung cancer.

31 May 2019

Biopharmaceutical News and Research

Enable Injections enters into a development agreement with Genentech

MSD collaborates with Francis Crick to find causes of motor neurone disease

Albumedix ground-breaking ceremony

Mallinckrodt publishes results of StrataGraft regenerative tissue Phase 1b study

Sartorius Stedim Biotech announces launch of new services for mammalian cell bank manufacturing

Promising antibody therapy reduces tumor growth, increases survival in mice with pancreatic cancer

Alzheimer's Association awards $3 million grant to support Longeveron's innovative clinical trial

Four young scientists receives Damon Runyon-Sohn Pediatric Cancer Fellowship Award

Quanterix to convene leading industry researchers at Alzheimer’s Association International Conference 2019 following closing of UmanDiagnostics acquisition

New alliance will focus on the structural visualization of novel druggable sites

Sartorius launches new ambr 250 modular bioreactor vessel for cell and gene therapy applications

Quanterix announces agreement to acquire UmanDiagnostics, world’s leading neurofilament light (Nf-l) antibody supplier

PhoreMost and C4XD sign neurodegeneration drug discovery collaboration agreement

Investigational drug for treatment of sickle cell disease shows early promise in clinical trials

Researchers identify new clues on tissue damage in rheumatoid arthritis and lupus

Topical cream found to be effective in reversing the effects of vitiligo

NCCN and AstraZeneca collaborate to improve care processes for lung cancer patients

Research provides new options for treatment of multi-drug resistant infections

Study discovers origin of neurofibromas that develop throughout the skin of NF1 patients

Electron microscopy project could revolutionize the search for new drugs

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News